UBS Group’s Core Scientific Inc Tranche 2 Warrants CORZZ Stock Holding History

UBS Group’s Portfolio CORZZ Stock Details CORZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.5K	Buy	1,507 +751	+99%	+$17.7K	﹤0.01%	7745
2026 Q1	$11.3K	Buy	756 +544	+257%	+$9.27K	﹤0.01%	8315
2025 Q4	$3.08K	Sell	212 -251	-54%	-$4.38K	﹤0.01%	9116
2025 Q3	$8.31K	Buy	463 +268	+137%	+$3.93K	﹤0.01%	8669
2025 Q2	$3.36K	Sell	195 -7,621	-98%	-$75.9K	﹤0.01%	9364
2025 Q1	$56.1K	Buy	7,816 +5,318	+213%	+$60.3K	﹤0.01%	7499
2024 Q4	$35K	Buy	2,498 +1,281	+105%	+$18.9K	﹤0.01%	7516
2024 Q3	$14.3K	Sell	1,217 -9,077	-88%	-$93.5K	﹤0.01%	7548
2024 Q2	$89.5K	Buy	+10,294	New	+$39.3K	﹤0.01%	6257

Other funds holding CORZZ

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

PWM

Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group's CORZZ Position: Q2 2026 in Review

UBS Group increased its Core Scientific Inc Tranche 2 Warrants (CORZZ) stake by 99% in Q2 2026, buying an estimated $17.7K and bringing the position to 1,507 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7745.

UBS Group first reported a position in CORZZ in Q2 2024 and has held it in 9 quarters since. The position peaked at $89.5K in Q2 2024. 30 funds tracked by Wall St. Rank hold CORZZ as of Q2 2026.

UBS Group held 1,507 shares of Core Scientific Inc Tranche 2 Warrants worth $37.5K as of Q2 2026.
UBS Group bought 751 Core Scientific Inc Tranche 2 Warrants shares in Q2 2026, an estimated $17.7K.
Core Scientific Inc Tranche 2 Warrants made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7745 holding.
UBS Group first reported a position in Core Scientific Inc Tranche 2 Warrants in Q2 2024 and has held it in 9 quarters since.
UBS Group's Core Scientific Inc Tranche 2 Warrants position peaked at $89.5K in Q2 2024.
30 funds tracked by Wall St. Rank held Core Scientific Inc Tranche 2 Warrants as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.